Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH was delisted on the 10th of June, 2024.
88 hedge funds and large institutions have $822M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 16 closing their positions.
59% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 22
3% more capital invested
Capital invested by funds: $795M → $822M (+$27.2M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
6% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 16
1% less funds holding
Funds holding: 89 → 88 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$16.2M |
| 2 |
Alkeon Capital Management
New York
|
+$13.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$10.6M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
+$7.78M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$5.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$24.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.99M |
| 3 |
JP Morgan Chase
New York
|
-$6.96M |
| 4 |
PC
PointState Capital
New York
|
-$6.86M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$5.24M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Man Group
London,
United Kingdom
| – | -$115K | -2,934 | Closed |
|
|
PIA
102
Piedmont Investment Advisors
Durham,
North Carolina
| – | -$5K | -132 | Closed |
|
|
MWM
103
Mascoma Wealth Management
Hanover,
New Hampshire
| – | -$2K | -40 | Closed |
|
|
MAM
104
Meeder Asset Management
Dublin,
Ohio
| – | -$1.38K | -35 | Closed |
|
DCPH Hedge Fund Activity: Q3 2018 in Review
88 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q3 2018, worth a combined $822M — up 3.4% from $795M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of DCPH and 15 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 35 added.
The largest buyer was State Street, adding an estimated $16.2M. The largest seller was Viking Global Investors, cutting an estimated $24.5M.
- 88 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q3 2018, down from 89 in Q2 2018.
- Funds reported $822M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q3 2018, up 3.4% quarter-over-quarter.
- 15 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q3 2018 and 16 closed out, a net change of -1 holder.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q3 2018 was State Street, an estimated $16.2M added.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q3 2018 was Viking Global Investors, an estimated $24.5M sold.
Based on aggregated 13F filings for Q3 2018.